Hydrocortisone made in yeast: Metabolic engineering turns a unicellular microorganism into a drug‐synthesizing factory
Authors:
- 17 March 2006
- journal article
- review article
- Published by Wiley in Biotechnology Journal
- Vol. 1 (3) , 299-307
Abstract
Inspired by the successful work of converting Saccharomyces cerevisiae into an microorganism capable of synthesizing hydrocortisone, a 27‐carbon molecule, from ethanol, a 2‐carbon molecule, this review provides an overview of the potential of yeast as a recombinant organism in the 21st century. Yeast has been used by man for more than 6000 years, and is still paving the way to new discoveries. It was the first eukaryotic organism to be sequenced, in 1996, and the first to produce hydrocortisone in 2003. In addition, extensive genome–wide analyses have been performed with yeast. In this review, we discuss the pros and cons of using yeast to produce small therapeutic molecules. It is obvious that S. cerevisiae has a cutting edge advantage of being a well–known organism and time will tell if yeast “biohydrocortisone” is a unique example or the beginning of a long list of yeast bioproducts. Other organisms, such as plants and bacteria, are competing with yeast. Bacteria produce a wealth of marketed molecules and plants are capable of producing extremely complex molecules with an unbeatable yield. However, S. cerevisiae offers a unique mix of the simplicity of a recombinant organism combined with the complexity of a eukaryote.Keywords
This publication has 51 references indexed in Scilit:
- Flux of sterol intermediates in a yeast strain deleted of the lanosterol C-14 demethylase Erg11pBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoidsToxicology and Applied Pharmacology, 2004
- Characterization of Recombinant Adrenodoxin Reductase Homologue (Arh1p) from YeastJournal of Biological Chemistry, 1998
- Life with 6000 GenesScience, 1996
- Functional Expression of Fused Enzymes Between Human Cytochrome P4501A1 and Human NADPH-Cytochrome P450 Oxidoreductase in Saccharomyces cerevisiaeDNA and Cell Biology, 1995
- Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased erod activityBiochemical and Biophysical Research Communications, 1992
- Progesterone metabolism in recombinant yeast simultaneously expressing bovine cytochromes P450cl7 (CYP17A1) and P450c21 (CYP21B1) and yeast NADPH-P450 oxidoreductasePharmacogenetics, 1991
- Purification and characterization of cytochrome P‐450sca from Streptomyces carbophilusEuropean Journal of Biochemistry, 1989
- Increased amounts of HMG-CoA reductase induce "karmellae": a proliferation of stacked membrane pairs surrounding the yeast nucleus.Journal of Cell Biology, 1988
- Prednisone in Rheumatoid Arthritis: Metabolic and Clinical EffectsAnnals of the Rheumatic Diseases, 1958